Date Initiated by Firm |
June 28, 2021 |
Create Date |
August 27, 2021 |
Recall Status1 |
Terminated 3 on July 25, 2022 |
Recall Number |
Z-2384-2021 |
Recall Event ID |
88396 |
510(K)Number |
K210525
|
Product Classification |
Monitor, pressure, intracompartmental - Product Code LXC
|
Product |
MY01 Continuous Compartmental Pressure Monitor, Reference Number MY01-0001 |
Code Information |
Lot Numbers: 9448532 9448838 9448979 9449000 9449237 |
Recalling Firm/ Manufacturer |
MY01, INC. 400 De Maisonneuve Blvd W Suite 700 Montreal Canada
|
Manufacturer Reason for Recall |
There is an incorrect version of the needle in the introducer part of devices. The affected Lots were manufactured using needles with a needle trocar geometry which is out of specification and may require a slightly higher push force from the user to penetrate the patient skin.
|
FDA Determined Cause 2 |
Under Investigation by firm |
Action |
A Medical Device Advisory Notice dated 6/28/21 was sent to customers.
Clinicians Responsibilities/ Actions required:
1. Review this notification for awareness of the contents
2. Identify and quarantine any unused affected products in your inventory for return
to MY01 Inc. Contact Customer Success team by phone (+1 (855) 292-6901) or
email (help@my01.io) to arrange for your replacements.
3. There are no specific patient monitoring instructions related to this voluntary
product removal that are recommended beyond your existing follow up schedule.
4. Complete Attachment 1- Certificate of acknowledgement and email to
help@my01.io by 07-Jul-2021.
5. Include a copy of Attachment 1- Certificate of acknowledgement with product
to be returned. Please use the return shipping label (to be provided by MY01
Inc.), please return affected product to:
Regulatory Affairs and Quality Management
MY01 Inc.
400 Maisonneuve Boulevard West,
Suite 700,
Montreal, Quebec,
Canada
H3A 1L4
6. Retain a copy of this document and Attachment 1- Certificate of
acknowledgement with your records.
7. If you have further questions or concerns after reviewing this notice, please call
the customer service team at 1-855-292-6901. Alternatively, your questions may
be emailed to: help@my01.io
Under 21 CFR 803, manufacturers are also required to report any serious injuries where
a product has contributed or may have contributed to the event. Please keep MY01 Inc.
informed of any adverse events associated with this by emailing help@my01.io or call
+1(855)-292-6901. |
Quantity in Commerce |
37 units |
Distribution |
US Nationwide distribution in the states of MD, OH, CA, NY. |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database |
510(K)s with Product Code = LXC and Original Applicant = MY01 Inc.
|